title: Mast cells in acute cellular rejection of human renal allografts.
abstract: Mast cells (MCs), few in the normal kidney, are found in increased number in the renal parenchyma in diseases associated with persistent chronic inflammation. MCs are not easily identified in routinely processed archival tissue sections with histochemical stains. A more reliable method of detection was provided with the introduction of MC tryptase-specific monoclonal antibodies. To determine the possible role of MCs in renal allograft rejection, we studied 28 biopsy specimens from renal allografts that had been in place for various lengths of time (from 3 days to 40 months) in patients whose primary diagnosis was acute interstitial rejection; the specimens were associated with varying degrees of interstitial fibrosis, edema, and hemorrhage. The specimens were graded on a semiquantitative scale (from 0 to 3+) for the severity of rejection, the degree of interstitial fibrosis, interstitial edema, and interstitial hemorrhage. Eosinophils, plasma cells, and MCs were quantitatively evaluated in these biopsy specimens. MCs were detected by use of a commercially available anti-MC tryptase monoclonal antibody, which proved to be an excellent tool to detect MCs in routinely processed paraffin sections. A positive correlation was found between the number of MCs and the time since transplantation (R = 0.841, P < 0.005) and between the number of MCs and the severity of interstitial fibrosis (R = 0.489, P < 0.005), as well as with interstitial edema (R = 0.517, P < 0.005). MCs were increased in number in patients with moderate (n = 18; mean, 18.00 MCs per 10 high power fields [HPFs]) and severe (n = 5; mean, 12.20 MCs per 10 HPFs) acute rejection compared with patients with mild (n = 5; mean, 2.44 MCs per 10 HPFs) acute rejection and normal kidneys (n = 6; mean, 1.75 MCs per 10 HPFs). These results suggested that MCs might play a role in the process of acute rejection of renal allografts and in the development of interstitial fibrosis.
authors.affiliation: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.
authors.forename: G
authors.initials: G
authors.lastname: Lajoie
authors.forename: T
authors.initials: T
authors.lastname: Nadasdy
authors.forename: Z
authors.initials: Z
authors.lastname: Laszik
authors.forename: K E
authors.initials: KE
authors.lastname: Blick
authors.forename: F G
authors.initials: FG
authors.lastname: Silva
mesh_terms: D000208:Acute Disease; D000328:Adult; D053818:Chymases; D004804:Eosinophils / Q000502:physiology; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007124:Immunoenzyme Techniques; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation / Q000473:pathology; D007958:Leukocyte Count; D008297:Male; D008407:Mast Cells / Q000502:physiology*; D008875:Middle Aged; D010950:Plasma Cells / Q000502:physiology; D012697:Serine Endopeptidases / Q000378:metabolism; D014184:Transplantation, Homologous; D053802:Tryptases
chemical_list: D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases